Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp ...

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...

GIBO Holdings Ltd. (NASDAQ: GIBO) today announced a significant technological breakthrough in its proprietary AIGC ...

As next-generation sequencing (NGS) applications expand, researchers face growing pressure to generate accurate, uniform data ...

Grail continues facing significant challenges as its stock plummeted over 45% after its landmark NHS-Galleri trial failed to ...

The Minister said India’s next priority is to transition AI in biotechnology from proof-of-concept research into scalable, industry-ready solutions through partnerships supported by BIRAC.

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex ...

Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...

Iberdomide has the potential to be the first approved CELMoD agentThe U.S. FDA has granted Breakthrough Therapy Designation and Priority Review for this indication and assigned a target action date of ...